Friday, July 20, 2018
8:00 - 8:50 AM

Registration Check-in & Networking Breakfast

8:50 - 9:00 AM

Welcome & Opening Remarks

Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director - Clarus

9:00 - 9:20 AM

Foundation Fighting Blindness Emerging Science Showcase

Introduced By:
Jason Menzo, COO - Foundation Fighting Blindness

Discovery of an Intravitreal AAV Vector, 4D-R100, for Use in Retina Gene Therapeutics
David Kirn, MD, CEO & Co-Founder - 4D Molecular Therapeutics

Next generation approaches to optogenetics
John G. Flannery, PhD, Professor - Photoswitch Therapeutics

RNA treatments targeting rare diseases
Daniel de Boer, CEO - ProQR Therapeutics

Retinal regeneration and photoreceptor reprogramming
Tom Reh, PhD, Professor, Department of Biological Structure - University of Washington

9:20 - 10:08 AM

Private Company Showcase

Introduced By:
Patrick Healy, Co-Founder, Executive Chairman - Trial Runners 

ONL Therapeutics | John Freshley, President & CEO
RFE Pharma | Alan Franklin, MD, PhD, Chief Medical Officer
Ocugenix | Sean McDonald, President & CEO
iRenix Medical | Stephen Smith, Founder & CEO
Eyedaptic | Jay Cormier, CEO
ZeaVision Holdings | Pinakin Davey, Professor and Director of Research - Western University, College of Optometry
Graybug Vision | Jeffrey Cleland, President & CEO
Allegro Ophthalmics | Vicken Karageozian, MD, President & Chief Medical Officer

10:08 - 10:46 AM

AM Networking & Refreshment Break

10:46 - 11:26 AM

Public Company Showcase

Introduced By:
Susan Benton, Head of Global Franchise Strategy and New Products, Ophthalmology - Shire 

Aerie Pharmaceuticals | Theresa Heah, MD, VP, Clinical Research, Medical and Professional Affairs
EyePoint Pharmaceuticals | Leonard BlumEVP & General Manager, U.S. 
Clearside Biomedical | Brion Raymond, Chief Commercial Officer
GenSight Biologics | Barrett Katz, MD, Chief Medical Officer
Spark Therapeutics | Thomas Ciulla, MD, Medical Strategy Lead, Ophthalmology

11:26 - 11:44 AM

Advances in Retinal Imaging 2018

Introduced By:
Craig Simak
, Co-Founder - OIS/CEO – Healthegy

Carl Zeiss Meditec | Angelo Rago, Global Head, Ophthalmic Diagnostics - Carl Zeiss Meditec
Heidelberg Engineering | Paul Bernstein MD, PhD, Professor of Ophthalmology and Visual Sciences - Moran Eye Center, University of Utah
Leica Microsystems | Houston Powell Sharpe III, Lead OCT Application Specialist - Leica Microsystems 

11:44 - 11:50 AM

Public Market Trends in Ophthalmology

Presented By:
Andrew Gitkin, Head of West Coast Biotechnology Investment Banking - Piper Jaffray

11:50 - 12:25 PM

Financing Environments 2018

Angela Macfarlane, Managing Member - ForSight Labs
Firas M. Rahhal, MD, Partner - ExSight Ventures
Ron Weiss, MD, Managing Member - InFocus Capital Partners 
Cameron Wheeler, Principal - Deerfield Management

Moderated By:
William J. Link, PhD, Managing Director - Versant Ventures

12:25 - 1:15 PM

Networking Lunch

1:15 - 1:50 PM

Retinal Drug Delivery

Mark Balles, MD, Founder - Retina Center of Maine
Eugene de Juan, MD, Founder & Managing Partner - ForSight Labs
Greg Grunberg, MD, Managing Director - Longitude Capital
Mark Wieland, MD - Northern California Retina Vitreous Associates
Daniel White, President & CEO - Clearside Biomedical

Moderated By:
Gilbert H. Kliman, MD, Managing Director - InterWest Partners

1:50 - 2:25 PM

Combination Therapies in AMD and DME

David Boyer, MD, Retina-Vitreous Associates Medical Group 
Jason Ehrlich, MD, PhD, Global Head, Clinical Ophthalmology Product Development - Genentech
Dante Pieramici, MD, Partner - California Retina Consultants
Charles Wykoff, MD Retina Consultants of Houston

Moderated By:
Peter Kaiser, MD, Professor of Ophthalmology - Cole Eye Institute

2:25 - 2:55 PM

PM Networking & Refreshment Break

2:55 - 3:30 PM

Retinal Gene Therapy 2018

Thomas Ciulla, MD, Medical Strategy Lead, Ophthalmology - Spark Therapeutics
Karl Csaky, MD, T. Boone Pickens Director - Clinical Center of Innovation for AMD/Managing Director & Chief Medical Officer - Retina Foundation of the Southwest
Barrett Katz, MD, Chief Medical Officer - GenSight Biologics
David Kirn, MD, CEO & Co-Founder - 4D Molecular Therapeutics 

Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director - Clarus

3:30 - 4:05 PM

Masters of Retina

Anthony Adamis, MD, SVP, Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science - Genentech
Kfir Azoulay, VP & Head, Corporate Strategy - Heidelberg Engineering
David Nicholson, PhD, Chief R&D Officer - Allergan
Angelo Rago, Global Head, Ophthalmic Diagnostics - Carl Zeiss Meditec
Calvin Roberts, MD, SVP, Chief Medical Officer - Bausch + Lomb

Moderated By:
Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec

4:05 - 4:10 PM

Closing Remarks

William J. Link, PhD, Managing Director - Versant Ventures

4:10 - 5:10 PM

Networking Reception